This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Steele, P. Articles by Genton, E. Search for Related Content PubMed PubMed Citation Articles by Steele, P. Articles by Genton, E.

Stroke, Vol 8, 396-398, Copyright © 1977 by American Heart Association

ARTICLES

Effect of sulfinpyrazone on platelet survival time in patients with transient cerebral ischemic attacks

P Steele, J Carroll, D Overfield and E Genton

Platelet suppressant drugs have been suggested as beneficial for patients with transient cerebral ischemic attacks and these drugs have been shown to lengthen shortened platelet survival time. In the present study platelet survival time (autologous labeling with 51Chromium) was measured in 25 patients with transient cerebral ischemia involving a carotid distribution. Platelet survival was shortened in all patients (2.5 +/- 0.10 days; AVE t 1/2 +/- SEM; Normal 3.7 +/- 0.04 days P less than 0.001). Sulfinpyrazone increased platelet survival in 9 of 19 (47%) of patients (2.4 +/- 0.10 to 2.8 +/- 0.16 days; P less than 0.01). Of the 19 treated with sulfinpyrazone, 10 had a marked reduction in the frequency of transient ischemic episodes and an increased in platelet survival (2.6 +/- 0.16 to 3.1 +/- 0.22 days; P less than 0.01) was observed in all patients. Three patients had no benefit from sulfinpyrazone and alteration of platelet survival did not occur. Results suggest that platelet survival is shortened in patients with transient cerebral ischemia, that sulfinpyrazone increases platelet curvival and may decrease the frequency of ischemic episodes, and that there may be a relationship between clinical benefit and alteration of platelet survival time.

This article has been cited by other articles:

				E. Osim, S. Mudzingwa, C. Musabayane, F. Mbajiorgu, and O. Munjeri The Effect of Chloroquine on Circulating Platelet Survival in the Rat Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1999; 4(2): 97 - 102. [Abstract] [PDF]